Atropine Sulfate Injection
Product Images NDC 51662-1311

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 51662-1311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Pouch Label (51662131121 Atropine Pouch Label)

Label for Atropine Sulfate Injection USP 8 mg/20 mL (0.4 mg/mL) 20 mL vial. The label includes the NDC number 51662-1311-2, lot number 12345, and expiration date 2030-06-30. It states that the product is manufactured by HF Acquisition Co., LLC in Mukilteo, WA, and is for intramuscular, intravenous, or subcutaneous use. The label also indicates "Rx Only."*

FDA Label Image

Case (51662131138 Atropine Case Label)

Label for Atropine Sulfate Injection USP, 8 mg/20 mL (0.4 mg/mL), 20 mL vial packaged in a box of 25. The label includes NDC 51662-1311-3, lot number 12345, and expiration date 2030-06-30. The product is indicated for intramuscular, intravenous, or subcutaneous use and is manufactured by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Serialized Rfid (51662131138 Atropine Rfid Label)

A small rectangular label featuring a barcode and a data matrix code. The label includes text with identifiers such as (01) 00351662131138, (17) 300630, (21) 70264922311, (10) 12345, and instructions to see the manufacturer's package insert. It states the product is distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275, and is marked RX ONLY.*

FDA Label Image

Adverse Event Tabel (Adverse Event)

A data table detailing adverse effects of atropine sulfate correlated with various dosage levels ranging from 0.5 mg to 65 mg. Symptoms include dryness of nose and mouth, bradycardia, tachycardia, mydriasis, speech disturbance, hallucinations, coma, and possible fatality at the highest dose.*

FDA Label Image

Dosage (Dosage)

A data table showing the required milliliters of Atropine Sulfate Solution for various milligram dosages. It compares volumes needed for concentrations of 1 mg per mL and 0.4 mg per mL, with entries for dosages ranging from 1 mg down to 0.10 mg.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial (Serialized 51662 1311 1 Atropine 20ml Vial)

Packaging label of Atropine Sulfate Injection, showing a clear glass vial with a white cap. The label indicates a strength of 8 mg per 20 mL. The product is for intramuscular, intravenous, and subcutaneous use, supplied as a 20 mL multidose vial. Distributed by HF Acquisition Co, LLC.*

FDA Label Image

Structure (Structure)

Chemical structure of atropine sulfate monohydrate shown as a molecular diagram with two atropine units associated with sulfuric acid and water molecules.*

FDA Label Image

Vial (Vial Label)

Label for Atropine Sulfate Injection, USP 0.4 mg/mL in a 20 mL multiple dose vial. The label states the total amount as 8 mg/20 mL, indicates use for intramuscular, intravenous, or subcutaneous administration, and includes manufacturer information for West-Ward. The label also lists inactive ingredients and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.